Skip to content

Insider · CIK 0001772652

Steve Mertens

officer

Files at NMTC (NEUROONE MEDICAL TECHNOLOGIES Corp). First filing -, latest -.

In brief

Steve Mertens files SEC Form 4 as officer at NMTC (NEUROONE MEDICAL TECHNOLOGIES Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Steve Mertens has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 10 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 28, 2026NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
AGrant or award
Option to Purchase Common Stockderivative
+15,000$0.00$015,000Aug 28, 2026
Mar 31, 2026NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
FTax withholding
Common Stock
-906$0.78$704152,141Apr 1, 2026
Feb 18, 2026NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
FTax withholding
Common Stock
-7,376$0.68$5,016153,047Feb 20, 2026
Dec 31, 2025NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
FTax withholding
Common Stock
-906$0.76$687160,423Jan 5, 2026
Sep 30, 2025NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
FTax withholding
Common Stock
-906$0.89$805161,329Oct 1, 2025
Jun 30, 2025NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
FTax withholding
Common Stock
-906$0.68$614162,235Jul 2, 2025
Apr 17, 2025NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
AGrant or award
Option to Purchase Common Stockderivative
+200,000$0.00$0200,000Apr 21, 2025
Mar 31, 2025NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
FTax withholding
Common Stock
-906$0.85$770163,141Apr 2, 2025
Nov 30, 2024NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
FTax withholding
Common Stock
-252$0.62$157172,833Dec 3, 2024
Oct 31, 2024NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
FTax withholding
Common Stock
-252$0.97$244173,085Nov 1, 2024

Questions about Steve Mertens

Answered from the filings on this page, as of the latest one.

Is Steve Mertens buying or selling?

Steve Mertens has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Steve Mertens's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Steve Mertens has 0.

Where does Steve Mertens file Form 4?

Steve Mertens has filed Form 4 at NMTC (NEUROONE MEDICAL TECHNOLOGIES Corp) as Chief Technology Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Steve Mertens: insider trades and track record | InsiderTell